论文部分内容阅读
恶性胸腔积液是晚期肺癌患者常见的并发症,患者生活质量因咳嗽、胸痛和呼吸困难等胸腔积液伴随症状的出现而受到影响。临床多采用胸膜腔内注入抗肿瘤药物或硬化剂抑制胸腔积液渗出和造成胸膜粘连,提高患者生活质量。各方研究报道不仅药物选择多种多样,相同药物胸膜腔内灌注的方法
Malignant pleural effusion is a common complication of patients with advanced lung cancer, the quality of life of patients affected by the emergence of symptoms associated with pleural effusion, such as cough, chest pain and dyspnea. More clinical use of intrapleural injection of anti-tumor drugs or sclerosing agent suppresses pleural effusion and pleural adhesions to improve the quality of life of patients. Various studies have reported not only a wide range of drug selection, the same method of drug infusion in the pleural cavity